BIND Therapeutics, Inc. - Investor Relations
BIND In the News. We are a clinical-stage nanomedicine platform company developing Accurins. A new class of targeted and programmable therapeutics developed using our Medicinal Nanoengineering. Platform. Accurins are nanoparticles designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease, enhancing efficacy while minimizing adverse effects on healthy tissues. We are developing our own pipeline. BIND Ther.
OVERVIEW
The domain ir.bindtherapeutics.com presently has a traffic ranking of zero (the smaller the better). We have inspected zero pages within the web site ir.bindtherapeutics.com and found one website referring to ir.bindtherapeutics.com. We have acquired three social communication accounts enjoyed by this website.
Links to this site
1Social Links
3IR.BINDTHERAPEUTICS.COM TRAFFIC
The domain ir.bindtherapeutics.com is seeing a alternation quantities of traffic until the end of the year.
Date Range
1 week
1 month
3 months
This Year
Last Year
All time
Date Range
All time
This Year
Last Year
Date Range
All time
This Year
Last Year
Last Month
LINKS TO DOMAIN
WHAT DOES IR.BINDTHERAPEUTICS.COM LOOK LIKE?
IR.BINDTHERAPEUTICS.COM SERVER
I revealed that the main page on ir.bindtherapeutics.com took one thousand seven hundred and ninety-seven milliseconds to download. Our crawlers could not find a SSL certificate, so our parsers consider ir.bindtherapeutics.com not secure.
Load time
1.797 secs
SSL
NOT SECURE
Internet Protocol
206.200.251.19
SERVER OS
We observed that ir.bindtherapeutics.com is weilding the Microsoft-IIS/6.0 server.HTML TITLE
BIND Therapeutics, Inc. - Investor RelationsDESCRIPTION
BIND In the News. We are a clinical-stage nanomedicine platform company developing Accurins. A new class of targeted and programmable therapeutics developed using our Medicinal Nanoengineering. Platform. Accurins are nanoparticles designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease, enhancing efficacy while minimizing adverse effects on healthy tissues. We are developing our own pipeline. BIND Ther.PARSED CONTENT
The domain states the following, "We are a clinical-stage nanomedicine platform company developing Accurins." We analyzed that the web site said " A new class of targeted and programmable therapeutics developed using our Medicinal Nanoengineering." It also stated " Accurins are nanoparticles designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease, enhancing efficacy while minimizing adverse effects on healthy tissues. We are developing our own pipeline."SEEK OTHER BUSINESSES
Blog de lady-blaack - Blog de lady-blaack - Skyrock.com
La cadence et sa reigne. Retape dans le champ ci-dessous la suite de chiffres et de lettres qui apparaissent dans le cadre ci-contre.
Bind Tuning Academy - Bind Tuning Academy
Customize Office 365 Sign In page.
COOKING ROCKS
Wednesday, 9 November 2.